Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Nephros (NEPH)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for NEPH as compared to
Top Competitors
Medical Instruments & Supplies
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
2.31M
AVG
EBITDA
►
-2.08M
AVG
Net Income
►
-2.45M
AVG
Revenue Growth
►
56.6%
AVG
Operating Margin
►
-116.1%
AVG
Net Margin
►
-106.1%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.359
AVG
Current Ratio
►
3.51
AVG
Quick Ratio
►
2.81
AVG
Interest Coverage Ratio
►
-1K
AVG
Book Value Per Share
►
0.0580
Cash Per Share
►
0.0431
Loading...
STOCK SUMMARY
Open
1.13
Day Range
1.12
-
1.18
52 Week Range
0.01
-
2.63
Volume
77K
Avg Volume (3 mo)
275K
Shares Outstanding
42.1M
Market Cap
47.1M
VALUATION
Price to Earnings (P/E)
►
-19.8
Price to Book (P/B)
►
20.1
AVG
Price to Sales (P/S)
►
21.0
AVG
Return on Assets (ROA)
►
-56.9%
AVG
Return on Equity (ROE)
►
-84.2%
AVG
EV/EBITDA
►
-24.2
Dividend Yield
0%
AVG
OWNERSHIP
Net Insider Buying 3mo
-1.9%
Net Insider Buying 6mo
-3.4%
Net Insider Buying 1yr
-6.9%
Held by insiders
95.7%
Held by institutions
0.1%
No Sales Breakout Data.